Main > ONCOLOGY (**) > Prostate Cancer Radioactive Diag. > USA. L. Piflufolastat F18 Inj



USA. L. Piflufolastat F18 Inj's subsections
(*) EU CE Mark Date: 2023. 07.28
(*) USA Approval Date: 2021. 05
Company
Company Licensee EU
Indicated for PET of PSMA+ Lesions>
Patent>EU Patent Numbers
Patent>USA Patent Numbers
RTM USA
RTM USA Web-Site
TM EU
TM EU Web-Site

USA. L. Piflufolastat F18 Inj's products
This section has no products